EST 0469B-comparison of high- and low-dose cyclophosphamide in human lung cancer

EST 0469B-comparison of high- and low-dose cyclophosphamide in human lung cancer

A controlled trial of high‐intermittent vs low‐chronic dose cyclophosphamide in human lung cancer failed to show the benefits reported in noncontrolled trials. There were no differences in toxicity observed.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical and pediatric oncology 1978, Vol.5 (1), p.231-240
Hauptverfasser: Hall, Thomas C., Pocock, Stuart, Brodovsky, Harvey, Horton, John, Shnider, Bruce I., Colsky, Jacob, Oberfield, Richard A.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Clinical Trials as Topic
cyclophosphamide
Cyclophosphamide - administration & dosage
Cyclophosphamide - adverse effects
Cytoxan
Drug Administration Schedule
Female
Hematopoiesis - drug effects
Humans
lung cancer
Lung Neoplasms - drug therapy
Male
Middle Aged
Time Factors
Vomiting - chemically induced
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A controlled trial of high‐intermittent vs low‐chronic dose cyclophosphamide in human lung cancer failed to show the benefits reported in noncontrolled trials. There were no differences in toxicity observed.
ISSN:0098-1532
1096-911X
DOI:10.1002/mpo.2950050132